TrialJournal of Korean medical science2014

A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction.

Jun-Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.